Mebeverine Acid
new
featured

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H556119

CAS#: 475203-77-1

Description: Mebeverine acid is a metabolite of the antispasmodic agent mebeverine.


Chemical Structure

img
Mebeverine Acid
CAS# 475203-77-1

Theoretical Analysis

Hodoodo Cat#: H556119
Name: Mebeverine Acid
CAS#: 475203-77-1
Chemical Formula: C16H25NO3
Exact Mass: 279.18
Molecular Weight: 279.380
Elemental Analysis: C, 68.79; H, 9.02; N, 5.01; O, 17.18

Price and Availability

Size Price Availability Quantity
25mg USD 550 2 Weeks
50mg USD 950 2 Weeks
100mg USD 1450 2 Weeks
200mg USD 2450 2 Weeks
Bulk inquiry

Synonym: Mebeverine Acid;

IUPAC/Chemical Name: 4-[ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino]-butanoic acid

InChi Key: UZUWRVLVHOYTNN-UHFFFAOYSA-N

InChi Code: InChI=1S/C16H25NO3/c1-4-17(11-5-6-16(18)19)13(2)12-14-7-9-15(20-3)10-8-14/h7-10,13H,4-6,11-12H2,1-3H3,(H,18,19)

SMILES Code: O=C(O)CCCN(CC)C(C)CC1=CC=C(OC)C=C1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 279.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Pyteraf J, Pacławski A, Jamróz W, Mendyk A, Paluch M, Jachowicz R. Application and Multi-Stage Optimization of Daylight Polymer 3D Printing of Personalized Medicine Products. Pharmaceutics. 2022 Apr 12;14(4):843. doi: 10.3390/pharmaceutics14040843. PMID: 35456677; PMCID: PMC9029863.


2: Gilad O, Rosner G, Brazowski E, Kariv R, Gluck N, Strul H. Management of pouch related symptoms in patients who underwent ileal pouch anal anastomosis surgery for adenomatous polyposis. World J Clin Cases. 2021 Nov 16;9(32):9847-9856. doi: 10.12998/wjcc.v9.i32.9847. PMID: 34877323; PMCID: PMC8610899.


3: Jia D, Gao Y, Williams GR. Core/shell poly(ethylene oxide)/Eudragit fibers for site-specific release. Int J Pharm. 2017 May 15;523(1):376-385. doi: 10.1016/j.ijpharm.2017.03.038. Epub 2017 Mar 23. PMID: 28344174.


4: Moskaleva NE, Baranov PA, Mesonzhnik NV, Appolonova SA. HPLC-MS/MS method for the simultaneous quantification of desmethylmebeverine acid, mebeverine acid and mebeverine alcohol in human plasma along with its application to a pharmacokinetics study. J Pharm Biomed Anal. 2017 May 10;138:118-125. doi: 10.1016/j.jpba.2017.02.006. Epub 2017 Feb 6. PMID: 28192719.


5: Almeida C, Ahmad SM, Nogueira JM. Bar adsorptive microextraction technique - application for the determination of pharmaceuticals in real matrices. Anal Bioanal Chem. 2017 Mar;409(8):2093-2106. doi: 10.1007/s00216-016-0156-y. Epub 2017 Jan 16. PMID: 28091717.


6: Lee KJ. Pharmacologic Agents for Chronic Diarrhea. Intest Res. 2015 Oct;13(4):306-12. doi: 10.5217/ir.2015.13.4.306. Epub 2015 Oct 15. PMID: 26576135; PMCID: PMC4641856.


7: Kiep L, Göhl M, Schmidt J, Seifert K. Studies on the Biotransformation of Veratric Acid, a Human Metabolite of Mebeverine, by Using the Incubated Hen's Egg. Drug Res (Stuttg). 2015 Sep;65(9):500-4. doi: 10.1055/s-0034-1390457. Epub 2014 Oct 13. PMID: 25310250.


8: Gubergrits NB, Lukashevich GM. [Cholestasis and pancreatic insufficiency: how to start treatment?]. Eksp Klin Gastroenterol. 2014;(8):84-90. Russian. PMID: 25911918.


9: Illangakoon UE, Nazir T, Williams GR, Chatterton NP. Mebeverine-loaded electrospun nanofibers: physicochemical characterization and dissolution studies. J Pharm Sci. 2014 Jan;103(1):283-92. doi: 10.1002/jps.23759. Epub 2013 Nov 20. PMID: 24258335.


10: Bergeron M, Bergeron A, van Amsterdam P, Furtado M, Garofolo F. Use of polarity switching for the simultaneous bioanalysis of analytes with three orders of magnitude difference in concentration by LC-MS/MS. Bioanalysis. 2013 Aug;5(15):1911-8. doi: 10.4155/bio.13.142. PMID: 23905864.


11: Abdelaleem EA, Abdelwahab NS. Validated chromatographic and spectrophotometric methods for analysis of some amoebicide drugs in their combined pharmaceutical preparation. Pak J Pharm Sci. 2013 Jan;26(1):175-83. PMID: 23261745.


12: Il'chenko IA, Deliukina OV. [Significance of biliary dysfunction in the pathogenesis of gallstone disease]. Eksp Klin Gastroenterol. 2011;(7):70-8. Russian. PMID: 22364003.


13: Walash MI, Kh Sharaf El-Din MM, El-Enany NM, Eid MI, Shalan SM. Simultaneous determination of sulpiride and mebeverine by HPLC method using fluorescence detection: application to real human plasma. Chem Cent J. 2012 Feb 14;6:13. doi: 10.1186/1752-153X-6-13. PMID: 22333299; PMCID: PMC3354339.


14: Lipnitskiĭ EM, Isakova OV, Movchun VA, Apdatskaia MD. [Effectiveness of duspatalin therapy in the treatment and prevention of post-cholecystectomy syndrome]. Vestn Ross Akad Med Nauk. 2011;(1):7-11. Russian. PMID: 21395089.


15: Elmasry MS, Blagbrough IS, Rowan MG, Saleh HM, Kheir AA, Rogers PJ. Quantitative HPLC analysis of mebeverine, mesalazine, sulphasalazine and dispersible aspirin stored in a Venalink monitored dosage system with co- prescribed medicines. J Pharm Biomed Anal. 2011 Mar 25;54(4):646-52. doi: 10.1016/j.jpba.2010.10.002. Epub 2010 Oct 14. PMID: 21106317.


16: Walash M, Sharaf El-Din M, El-Enany N, Eid M, Shalan Sh. First derivative synchronous fluorescence spectroscopy for the simultaneous determination of sulpiride and mebeverine hydrochloride in their combined tablets and application to real human plasma. J Fluoresc. 2010 Nov;20(6):1275-85. doi: 10.1007/s10895-010-0679-0. Epub 2010 Jul 7. PMID: 20607372.


17: Abdullah GZ, Abdulkarim MF, Chitneni M, Mutee AF, Ameer OZ, Salman IM, Noor AM. Preparation and in vitro evaluation of mebeverine HCl colon-targeted drug delivery system. Pharm Dev Technol. 2011 Aug;16(4):331-42. doi: 10.3109/10837451003739255. Epub 2010 Apr 30. PMID: 20429815.


18: Maskaoui K, Zhou JL. Colloids as a sink for certain pharmaceuticals in the aquatic environment. Environ Sci Pollut Res Int. 2010 May;17(4):898-907. doi: 10.1007/s11356-009-0279-1. Epub 2009 Dec 19. PMID: 20024675.


19: Lipnitskiĭ EM, Isakova OV, Dzhadzhanidze AD, Ardatskaia MD. [Efficacy of duspatalin in the treatment and prophylaxis of postcholecystectomic syndrome]. Eksp Klin Gastroenterol. 2008;(3):86-93. Russian. PMID: 19145887.


20: Omar S, Aldosari B, Refai H, Gohary OA. Colon-specific drug delivery for mebeverine hydrochloride. J Drug Target. 2007 Dec;15(10):691-700. doi: 10.1080/10611860701603281. PMID: 18041637.